Annual ROE
-23.07%
-4.88%-26.83%
December 31, 2024
Summary
- As of March 12, 2025, ITOS annual return on equity is -23.07%, with the most recent change of -4.88% (-26.83%) on December 31, 2024.
- During the last 3 years, ITOS annual ROE has fallen by -72.05% (-147.10%).
- ITOS annual ROE is now -137.08% below its all-time high of 62.22%, reached on December 31, 2019.
Performance
ITOS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-22.15%
-2.04%-10.14%
December 31, 2024
Summary
- As of March 12, 2025, ITOS quarterly return on equity is -22.15%, with the most recent change of -2.04% (-10.14%) on December 31, 2024.
- Over the past year, ITOS quarterly ROE has dropped by -2.04% (-10.14%).
- ITOS quarterly ROE is now -133.29% below its all-time high of 66.53%, reached on June 30, 2022.
Performance
ITOS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ITOS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.8% | -10.1% |
| 3 y3 years | -147.1% | -139.4% |
| 5 y5 years | -137.1% | -135.6% |
ITOS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -147.1% | at low | -133.3% | +2.1% |
| 5 y | 5-year | -137.1% | at low | -133.3% | +50.9% |
| alltime | all time | -137.1% | +80.8% | -133.3% | +50.9% |
ITeos Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -23.07%(+26.8%) | -22.15%(+10.1%) |
| Sep 2024 | - | -20.11%(+11.7%) |
| Jun 2024 | - | -18.01%(-20.4%) |
| Mar 2024 | - | -22.62%(+25.0%) |
| Dec 2023 | -18.19%(-214.5%) | -18.09%(+86.1%) |
| Sep 2023 | - | -9.72%(+119.9%) |
| Jun 2023 | - | -4.42%(-346.9%) |
| Mar 2023 | - | 1.79%(-88.5%) |
| Dec 2022 | 15.89% | 15.52%(-66.4%) |
| Sep 2022 | - | 46.24%(-30.5%) |
| Jun 2022 | - | 66.53%(+2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 64.68%(+15.1%) |
| Dec 2021 | 48.98%(-516.1%) | 56.20%(+1135.2%) |
| Sep 2021 | - | 4.55%(-121.9%) |
| Jun 2021 | - | -20.80%(+24.0%) |
| Mar 2021 | - | -16.78%(+2.7%) |
| Dec 2020 | -11.77%(-118.9%) | -16.34%(-18.0%) |
| Sep 2020 | - | -19.93%(-36.5%) |
| Jun 2020 | - | -31.40%(-30.3%) |
| Mar 2020 | - | -45.08%(-172.5%) |
| Dec 2019 | 62.22%(-151.9%) | 62.22% |
| Dec 2018 | -119.96% | - |
FAQ
- What is iTeos Therapeutics annual return on equity?
- What is the all time high annual ROE for iTeos Therapeutics?
- What is iTeos Therapeutics annual ROE year-on-year change?
- What is iTeos Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly ROE year-on-year change?
What is iTeos Therapeutics annual return on equity?
The current annual ROE of ITOS is -23.07%
What is the all time high annual ROE for iTeos Therapeutics?
iTeos Therapeutics all-time high annual return on equity is 62.22%
What is iTeos Therapeutics annual ROE year-on-year change?
Over the past year, ITOS annual return on equity has changed by -4.88% (-26.83%)
What is iTeos Therapeutics quarterly return on equity?
The current quarterly ROE of ITOS is -22.15%
What is the all time high quarterly ROE for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly return on equity is 66.53%
What is iTeos Therapeutics quarterly ROE year-on-year change?
Over the past year, ITOS quarterly return on equity has changed by -2.04% (-10.14%)